Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111574403A reveals a low-cost Co-Mn-Br catalyzed oxidation route for high-purity p-cyanobenzoic acid, offering significant supply chain advantages.
Patent CN1078590C reveals a catalytic hydrogenation route for 2-oxindole. Achieve cost reduction in API manufacturing with high-purity intermediates and scalable supply.
Patent CN112195203A details enzymatic synthesis of S-2-aminobutanamide. High purity, reduced costs, and scalable pharmaceutical intermediates manufacturing for global supply chains.
Advanced preparation of Sofosbuvir key intermediate via stable phosphorylation. Reduces cost and eliminates chromatography for reliable pharmaceutical intermediate supply.
Patent CN105061300B reveals a high-yield chloro-pyridine method. Discover cost-effective supply chain solutions and scalable manufacturing for global pharmaceutical intermediates.
Patent CN104788474B reveals metal-free synthesis for triazole benzothiazinone intermediates. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN101781197B reveals a high-yield route for chiral binaphthyl dicarboxylic acid. Achieve >99% optical purity without chromatography for cost-effective supply.
Advanced recrystallization patent for Hepatitis C drug intermediates. Delivers high-purity crystals, solvent recovery, and scalable manufacturing for global supply chains.
Novel patent CN117820190A enables high-yield synthesis of 4 6 dichloro pyrrolo pyridine intermediates ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN102643757B reveals a novel biocatalytic route for statin intermediates. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN110563590A reveals a solvent-free ball milling method for toluene oxidation. This report analyzes cost reduction and supply chain reliability for high-purity intermediates.
Discover a novel MnO2-catalyzed synthesis for Avatrombopag N-Oxide impurity. Enhanced yield and purity for reliable pharmaceutical intermediate supply chains.
Novel enzymatic method for UDCA and TUDCA from pig bile. High purity, scalable process. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN101759536A reveals a green oxidation method for p-hydroxybenzaldehyde using metalloporphyrins, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel electrocatalytic route for indolizine derivatives offers metal-free synthesis, high yields, and scalable production for pharmaceutical intermediates.
Patent CN101007785B details a green synthesis for quinocetone metabolites. Discover cost-effective, high-purity manufacturing solutions for veterinary drug intermediates.
Novel calcium hydroxide catalyzed route for 3-methylquinoxaline-2-carboxylic acid. Enhances supply chain reliability and reduces manufacturing complexity for veterinary drug residue markers.
Patent CN1369500A details a novel chemical synthesis for bioactive Panax notoginseng polysaccharide fragments, offering high-purity pharmaceutical intermediates with scalable production capabilities.
Patent CN103492409B details a one-pot Micafungin synthesis reducing isolation steps. This offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply reliability.
Novel patent CN103613582A offers high-yield rosuvastatin lactone synthesis ensuring cost reduction and supply chain reliability for global pharma manufacturers.